John W. Ferkany

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

Paul M. Sweetnam, Jean Lancaster, Adele M. Snowman et al. · Psychopharmacology · 1995 · 109 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection

Povl Krogsgaard‐Larsen, John W. Ferkany, Elsebet Ø. Nielsen et al. · Journal of Medicinal Chemistry · 1991 · 63 citations

Medicine, Neuroscience, Pharmacology +14

Blockade of mu and kappa1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist

Yuri Kolesnikov, John W. Ferkany, Gavril W. Pasternak · Life Sciences · 1993 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

D.L. deHaven-Hudkins, P.A. Brostrom, Jeremy Allen et al. · Pharmacology Biochemistry and Behavior · 1990 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +10